[1]王金梅,张　凯,刘凡凡,等.雷帕霉素脂质纳米粒的制备及其对裸鼠乳腺癌的抑制作用[J].新乡医学院学报,2022,39(6):507-512.[doi:10.7683/xxyxyxb.2022.06.002]
　WANG Jinmei,ZHANG Kai,LIU Fanfan,et al.Preparation of rapamycin loaded lipid nanoparticles and its inhibitory effect on breast cancer in nude mice[J].Journal of Xinxiang Medical University,2022,39(6):507-512.[doi:10.7683/xxyxyxb.2022.06.002]
点击复制

雷帕霉素脂质纳米粒的制备及其对裸鼠乳腺癌的抑制作用
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
39
期数:
2022年6
页码:
507-512
栏目:
基础研究
出版日期:
2022-06-05

文章信息/Info

Title:
Preparation of rapamycin loaded lipid nanoparticles and its inhibitory effect on breast cancer in nude mice
作者:
王金梅; 张　凯; 刘凡凡; 丁孝良
(郑州大学附属郑州中心医院药学部,河南　郑州　450000)
Author(s):
WANG Jinmei; ZHANG Kai; LIU Fanfan; DING Xiaoliang
(Department of Pharmacy,Zhengzhou Central Hospital Affiliated to Zhengzhou University,Zhengzhou 450000,Henan Province,China)
关键词:
雷帕霉素; 脂质纳米粒; 抗肿瘤活性
Keywords:
rapamycin; lipid nanoparticles; anti-cancer activity
分类号:
R703.5
DOI:
10.7683/xxyxyxb.2022.06.002
文献标志码:
A
摘要:
目的　制备载雷帕霉素（RAPA）的介孔二氧化硅（MSN）核-脂质纳米粒（RAPA-MSN-LN），观察RAPA-MSN-LN对裸鼠乳腺癌的抑制作用。方法　采用薄膜分散法制备RAPA-MSN-LN，对RAPA-MSN-LN进行质量评价。以RAPA为对照，观察RAPA-MSN-LN在大鼠体内的药物代谢动力学。取生长状态良好的乳腺癌细胞MCF-7皮下接种于30只BALB/c裸鼠右前腋窝（每只200 μL）制备荷瘤裸鼠模型，取肿瘤体积为100～150 mm3的荷瘤小鼠20只，随机分为生理盐水组、MSN-LN组、RAPA组和RAPA-MSN-LN组，每组5只。生理盐水组、MSN-LN组、RAPA组和RAPA-MSN-LN组小鼠分别经尾静脉注射生理盐水、MSN-LN、RAPA和RAPA-MSN-LN溶液，隔日给药1次，共给药6次，各组小鼠给药剂量均为2.50 mg·kg-1。观察4组小鼠体质量和肿瘤体积的变化，采用苏木精-伊红（HE）染色和原位末端转移酶标记（TUNEL）染色观察4组小鼠主要器官组织和肿瘤组织的病理组织学变化。结果　制备的RAPA-MSN-LN形状规则，呈圆形，MSN表面包裹了一层脂质薄膜，分散状态良好。RAPA-MSN-LN的平均粒径为（91.27±2.26） nm，多分散性指数为0.165±0.024，电位为（-21.60±2.21）mV，包封率为（42.1± 2.1）%。体内药物代谢动力学实验结果显示，RAPA-MSN-LN在血浆中的半衰期和血药浓度-时间曲线下面积值均高于RAPA（P<0.01）。体内抗肿瘤实验结果显示，4组小鼠体质量均缓慢增长，RAPA-MSN-LN组小鼠的肿瘤体积最小。HE、TUNEL染色结果显示，4组小鼠的主要器官组织结构清晰且无坏死现象。生理盐水组和MSN-LN组小鼠肿瘤组织中肿瘤细胞排列紧密，形态完整，几乎无凋亡细胞；RAPA组小鼠肿瘤组织中出现小范围的细胞凋亡，肿瘤组织出现部分坏死，肿瘤细胞数量减少；RAPA-MSN-LN组小鼠肿瘤组织中坏死区域最多，核固缩、核溶解现象较明显，肿瘤组织中凋亡细胞数较多，细胞核出现消融和萎缩。 结论　RAPA-MSN-LN能够提高药物的生物利用度，对小鼠无毒副作用，在体内具有明显的抗乳腺癌作用，有望成为一种高效、低毒的肿瘤治疗药物。
Abstract:
Objective　To prepare rapamycin（RAPA） loaded mesoporous silica nanoparticles (MSN) core-lipid nanoparticles (RAPA-MSN-LN) and investigate the inhibitory effect of RAPA-MSN-LN on breast cancer in nude mice.Methods　RAPA-MSN-LN were prepared by thin-film dispersion method and the quality of RAPA-MSN-LN was evaluated.The pharmacokinetics of RAPA-MSN-LN in rats was observed with RAPA as control.The human breast cancer cells MCF-7 in good growth condition was subcutaneously inoculated into the right anterior armpit (200 μL) of 30 BALB/c nude mice to prepare the tumor bearing nude mouse model.Twenty tumor bearing mice with tumor volume of 100-150 mm3 were randomly divided into normal saline group,MSN-LN group,RAPA group and RAPA-MSN-LN group,with 5 mice in each group.The mice in the normal saline group,MSN-LN group,RAPA group and RAPA-MSN-LN group were injected with normal saline,MSN-LN,RAPA and RAPA-MSN-LN solution through caudal vein,once every other day for a total of 6 times,the drug dosage of mice in each group was 2.50 mg·kg-1.The changes of body mass and tumor volume of mice in the four groups were observed.The histopathological changes of main organs and tumor tissues of mice in the four groups were observed by hematoxylin-eosin (HE) staining and TdT-mediated dUTP nick end labeling (TUNEL) staining.Results　The shape of RAPA-MSN-LN was regular and round.The surface of MSN was wrapped with a layer of lipid film,and the dispersion was good.The average particle size was (91.27±2.26) nm,the polymey disperse index was 0.165±0.024,the potential was (-21.60±2.21) mV,the entrapment efficiency was (42.1±2.1)%.In vivo pharmacokinetics experiments showed that the half-life and the area under the plasma concentration-time curve of RAPA-MSN-LN in plasma were higher than those of RAPA (P<0.01).The results of anti-tumor experiment in vivo showed that the body mass of mice in the four groups increased slowly,and the volume of tumor in the mice in the RAPA-MSN-LN group was the smallest.The HE and TUNEL staining results showed that the tissues of main organs of mice in the four groups were clear without necrosis.In the normal saline group and MSN-LN group,the tumor cells were closely arranged,with complete morphology and there was almost no apoptotic cells;in the RAPA group,there was a small range of apoptosis in tumor tissue,partial necrosis in tumor tissue,and the number of tumor cells decreased;in the RAPA-MSN-LN group,the necrotic area in the tumor tissue was the most,the phenomenon of nuclear pyknosis and nucleolysis was more obvious,the number of apoptotic cells in tumor tissue were more,and the nucleus appeared ablation and atrophy.Conclusion　RAPA-MSN-LN can improve the bioavailability of drugs,it has no toxic and side effects on mice and its anti-cancer effect was obvious,which is expected to be a highly effective and low toxiccancer drugs.

参考文献/References:

［1］　ZHAO M,DING X,SHEN J,et al.Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice［J］.J Zhejiang Univ Sci B,2017,18(1):15-26.
［2］　叶鹏，陈莉，李丹，等.多西他赛固体脂质纳米粒抗乳腺癌效果及机制研究［J］.现代生物医学进展,2016，16(33)：6429-6432.
YE P,CHEN L,LI D,et al.Anti breast cancer effect and mechanism of docetaxel solid lipid nanoparticles［J］.Progress Modern Biomed,2016,16(33)：6429-6432.
［3］　刘力，刘国文，谭米多.乳腺癌的综合治疗现状［J］.中国肿瘤外科杂志,2013，5(1):60-63.
LIU L,LIU G W,TAN M D.Comprehensive treatment of breast cancer［J］.Chin J Surgical Oncol,2013，5(1):60-63.
［4］　PAQUETTE M,EL-HOUJEIRI L PAUSE A.mTOR pathways in cancer and autophagy［J］.Cancers (Basel),2018,10(1)：18.
［5］　LAPLANTE M,SABATINI D M.mTOR signaling in growth control and disease［J］.Cell,2012,149(2):274-293.
［6］　胡平亚，方国英，史东明.西罗莫司的抗肿瘤应用及不良反应概述［J］.中国药师,2014,17(1):156-158.
HU P Y,FANG G Y,SHI D M.Overview of antitumor application and adverse reactions of sirolimus［J］.China Pharmacist,2014,17(1):156-158.
［7］　张晓元，郝荣华，飞刘，等.雷帕霉素在肿瘤治疗方面研究进展［J］.食品与药品,2018,20(1):65-70.
ZHANG X Y，HAO R H，LIU F,et al.Progress in application of rapamycin in tumor treatment［J］.Food Drug,2018,20(1):65-70.
［8］　TROUTIER A,LADAVIRE C. An overview of lipid membrane supported by colloidal particles［J］.Adv Colloid Interface Sci,2007,133(1):1-21.
［9］　KOPECKA J,CAMPIA I,OLIVERO P,et al.A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells［J］.J Control Release,2011,149(2):196-205.
［10］　HAO Y,ZHENG C,WANG L,et al.Tumor acidity-activatable manganese phosphate nanoplatform for amplification of photodynamic cancer therapy and magnetic resonance imaging［J］.Acta Biomater,2017,62:293-305.
［11］　DAI Y,XU C,SUN X,et al.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment［J］.Chem Soc Rev,2017,46(12):383-3852.
［12］　WANG L,NIU M,ZHENG C,et al.A Core-shell nanoplatform for synergistic enhanced sonodynamic therapy of hypoxic tumor via cascaded strategy［J］.Adv Healthc Mater,2018:1800819.
［13］　WANG L,HU Y,HAO Y,et al.Tumor-targeting core-shell structured nanoparticles for drug procedural controlled release and cancer sonodynamic combined therapy［J］.J Control Release,2018,286:74-84.
［14］　AL-TWEIGERI T,ALSAYED A,ALAWADI S,et al.A multicenter prospective phase II trial of neoadjuvant epirubicin,cyclophosphamide,and 5-fluorouracil (FEC100) followed by cisplatin-docetaxel with or without trastuzumab in locally advanced breast cancer［J］.Cancer Chemother Pharmacol,2016,77(1):147-153.
［15］　LU W L,LI H X,QIAN B Y,et al.The clinical characteristics and prognosis of chinese early stage breast cancer patients：a retrospective study［J］.Breast J,2010,16(3):331-333.

相似文献/References:

[1]张彦选,曲青山,张贵虎,等.肾移植受者应用吗替麦考酚酯与雷帕霉素的成本-效果分析[J].新乡医学院学报,2010,27(04):388.
[2]肖蓬莉,郭淑利,王双琳,等.三氧化二砷联合雷帕霉素对急性髓系白血病THP-1细胞增殖、凋亡及自噬的影响[J].新乡医学院学报,2020,37(9):818.[doi:10.7683/xxyxyxb.2020.09.003]
　XIAO Pengli,GUO Shuli,WANG Shuanglin,et al.Effects of arsenic trioxide combined with rapamycin on proliferation，apoptosis and autophagy of acute myeloid leukemia THP-1 cells[J].Journal of Xinxiang Medical University,2020,37(6):818.[doi:10.7683/xxyxyxb.2020.09.003]
[3]许鑫,杨君,赵金金,等.雷帕霉素对多囊卵巢综合征大鼠子宫内膜的作用及机制[J].新乡医学院学报,2023,40(9):818.[doi:10.7683/xxyxyxb.2023.09.003]
　XU Xin,YANG Jun,ZHAO Jinjin,et al.Effect and mechanism of rapamycin on endometrium of rats with polycystic ovary syndrome[J].Journal of Xinxiang Medical University,2023,40(6):818.[doi:10.7683/xxyxyxb.2023.09.003]
[4]王金梅,张凯,张颖,等.雷帕霉素核壳型pH敏感递药系统制备及其对乳腺癌细胞的体外作用[J].新乡医学院学报,2024,(4):316.[doi:10.7683/xxyxyxb.2024.04.003]
　WANG Jinmei,ZHANG Kai,ZHANG Ying,et al.Preparation of rapamycin-loaded core-shell pH-sensitive drug delivery system and its effect on breast cancer cells in vitro[J].Journal of Xinxiang Medical University,2024,(6):316.[doi:10.7683/xxyxyxb.2024.04.003]

更新日期/Last Update: 2022-06-05